Loading…

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure

In the majority of these studies, cTnT or cTnI cutoff concentrations were higher than either the 99th percentile or the 10% CV value. These and other studies have consistently shown that postprocedural increases in cTn and/or CK-MB are associated with major adverse clinical events.

Saved in:
Bibliographic Details
Published in:Clinical chemistry (Baltimore, Md.) Md.), 2007-12, Vol.53 (12), p.2086-2096
Main Authors: NACB WRITING GROUP MEMBERS, Wu, Alan H.B, Jaffe, Allan S, Apple, Fred S, Jesse, Robert L, Francis, Gary L, Morrow, David A, Newby, L. Kristin, Ravkilde, Jan, Tang, W.H. Wilson, Christenson, Robert H, NACB COMMITTEE MEMBERS, Cannon, Christopher P, Storrow, Alan B
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the majority of these studies, cTnT or cTnI cutoff concentrations were higher than either the 99th percentile or the 10% CV value. These and other studies have consistently shown that postprocedural increases in cTn and/or CK-MB are associated with major adverse clinical events.
ISSN:0009-9147
1530-8561
DOI:10.1373/clinchem.2007.095679